Japan is the world's third-largest cosmetics market, and its regulatory architecture operates on two parallel tracks. The first is the customs import structure under the Customs Act (関税法): who is the importer of record (輸入者), what entity files the import declaration (輸入申告), and who pays customs duties and import consumption tax. The second is the marketing authorization layer under the Pharmaceutical and Medical Device Act (薬機法, commonly referred to as the PAL Act): who holds the cosmetics manufacturing and marketing authorization (化粧品製造販売業許可) required to place products on the Japan market. Getting either layer wrong produces distinct, compounding problems. This article covers the customs layer. The PAL Act marketing authorization layer requires specialist regulatory advice specific to your product formulations and label claims.
Cosmetics vs. Quasi-Drugs: Classify Before You Plan
Japan draws a firm line between cosmetics (化粧品) and quasi-drugs (医薬部外品). Products marketed and sold as ordinary cosmetics in the EU or United States are frequently classified as quasi-drugs in Japan, depending on the active ingredient and the label claims made. Quasi-drug classification triggers a requirement for prior product approval (承認) from the Ministry of Health, Labour and Welfare (厚生労働省), a substantially more time-intensive process than cosmetic-only import notification.
Classification must be confirmed with a Japan regulatory specialist before the first shipment is planned. A product that arrives at the Japanese border without the correct classification and approval status is subject to import refusal. Reclassification after the fact is not available as a clearance strategy.
The Customs Import Structure: Two Distinct Options
A non-resident cosmetics brand importing into Japan has two structural options under the Customs Act (関税法). These are legally distinct and serve different commercial profiles. They are not interchangeable and should never be treated as a binary choice under a single description. Each is set out separately below, with IOR addressed first.
**Importer of Record (IOR)**
Under the IOR structure, Aplash acts as the legal importer named on the import declaration. Aplash purchases the goods from the overseas brand, files the customs import declaration in its own name, and pays customs duties and import consumption tax (消費税). Aplash then re-sells the goods to the Japan-side buyer, which may be a distributor, a marketing authorization holder, or both.
Commercial and legal implications for the brand:
(a) The overseas brand has no direct Japan customs exposure. The brand is not named on the import declaration and is not liable for customs duties or import tax as a principal.
(b) Japan consumption tax (消費税) is handled entirely by Aplash. Aplash pays import JCT as importer of record and recovers it as an input credit through its own JCT filings. Aplash issues a qualified invoice (適格請求書) to the Japan buyer, enabling the buyer to claim its own input credit. The overseas brand requires no Japan JCT registration under this structure.
(c) Aplash's IOR engagement is a genuine buy-and-sell transaction. Aplash takes commercial title to the goods before the import declaration is filed. This is not a name-lending arrangement. Japanese customs law requires the named importer to hold actual legal rights over the goods at the time of import; an IOR engagement without genuine title transfer constitutes a false customs declaration and is prohibited.
PAL Act alignment note: The IOR structure governs who files customs paperwork. It does not provide or substitute for PAL Act marketing authorization. The Japan party receiving goods from Aplash under the re-sale agreement must independently hold a valid cosmetics manufacturing and marketing authorization. If that authorization is not in place before the first shipment, the goods cannot lawfully enter commercial sale in Japan regardless of the import declaration structure.
**Attorney for Customs Procedures (ACP, 税関事務管理人)**
Under the ACP structure, the overseas brand is named directly on the import declaration as the importer of record. Aplash is appointed as the brand's Attorney for Customs Procedures (税関事務管理人) under Article 95 of the Customs Act (関税法), which permits a non-resident entity to import goods into Japan by designating a Japan-resident as its statutory customs contact and procedural agent.
Commercial and legal implications for the brand:
(a) The brand retains title and commercial control over the goods at all stages. Aplash does not take title and is not a party to the commercial transaction between the brand and its Japan distributor.
(b) Because the brand is named as importer, the brand bears direct liability for customs duties and import JCT. Import JCT is recoverable, but only if the brand registers as a Qualified Invoice Issuer (適格請求書発行事業者) under Japan's Qualified Invoice System (インボイス制度) and separately appoints a Tax Representative (納税管理人). Registration under the Qualified Invoice System typically takes four to six weeks. This registration must be completed before the first shipment arrives. Import JCT paid before registration is confirmed is permanently irrecoverable. There is no retroactive mechanism.
(c) Aplash acts as statutory customs contact only under this structure. Aplash's role is procedural: receiving customs notices, coordinating with the customs broker on declarations, and ensuring the brand's Japan compliance obligations are administered. Aplash does not direct the commercial transaction.
PAL Act alignment note: Because the brand is named as importer under ACP, this structure aligns more naturally with the brand holding or sponsoring the Japan marketing authorization. However, a non-resident brand still requires a Japan-resident entity to hold the cosmetics manufacturing and marketing authorization. PAL Act licensing requires a Japan-resident representative. The ACP structure on the customs side does not remove that requirement.
Japan-Specific Compliance Requirements for Cosmetics
These requirements apply regardless of which customs structure is chosen. They are independent of the import declaration structure and are not resolved by appointing an IOR or an ACP.
Ingredient restrictions. Japan maintains its own approved and restricted ingredient list, administered by the Ministry of Health, Labour and Welfare (厚生労働省). This list is not harmonized with the EU Cosmetics Regulation or with US Food and Drug Administration guidance. Every formulation must be reviewed against Japan's current permitted ingredient framework before import. An ingredient lawful in the EU or US may be prohibited or restricted in Japan.
Labeling. Japanese-language labels are mandatory. Ingredients must be listed using Japan's systematic cosmetic ingredient nomenclature (化粧品成分表示名称). Labels must also state the net content, the expiry date, and the name and address of the Japan-side marketing authorization holder. Labels formatted for EU or US markets cannot be used without revision.
Import notification. Under the PAL Act (薬機法), cosmetics imported for commercial sale into Japan require advance notification to the Ministry of Health, Labour and Welfare (厚生労働省). This notification is separate from the customs clearance process and must be handled by or under the authority of the marketing authorization holder.
Choosing the Right Structure
Choose IOR when:
(a) The brand wants no direct Japan customs or tax exposure on import declarations.
(b) Import volumes do not justify establishing a Japan-side Qualified Invoice System registration and Tax Representative structure before the first shipment.
(c) Speed to first shipment is a priority and the full ACP tax registration chain cannot be completed in the available timeline.
(d) The brand's distribution agreement places the Japan buyer as the commercial principal post-import, and re-sale by Aplash to that buyer is structurally clean.
Choose ACP when:
(a) The brand's distribution or licensing agreement requires the brand to appear as the named importer on Japan customs documents.
(b) Import volumes make direct JCT recovery commercially significant, and the brand can complete the Qualified Invoice System registration and Tax Representative appointment before the first shipment.
(c) The brand is planning Japan market presence or entity establishment and wishes to build a customs compliance history under its own name.
(d) The brand's global product liability framework or insurance structure requires it to be named as importer in each jurisdiction where goods enter commercial distribution.
Common Entry Errors
(a) Treating the Japan distributor as default importer. A consignment or agency distributor that does not hold commercial title to the goods, and that does not hold disposition rights (処分権限) over them, cannot lawfully be named as importer of record on the import declaration. Appointing a distributor as nominal importer without actual title is a customs declaration violation under the Customs Act (関税法).
(b) Assuming EU or US product approval transfers to Japan. Japan's ingredient approval framework, quasi-drug classification system, and labeling rules are independent of other jurisdictions. Prior EU or US regulatory clearance has no effect on Japan customs review or PAL Act requirements.
(c) Shipping under ACP before Qualified Invoice System registration is confirmed. Import JCT paid before the brand completes registration as a Qualified Invoice Issuer and appoints a Tax Representative is permanently irrecoverable. This is a structural cutoff with no correction available after the fact.
(d) Misaligning the customs structure with the PAL Act marketing authorization structure. A brand that uses ACP and appears as named importer but has not arranged for a Japan-side marketing authorization holder creates an operational conflict at post-clearance. Goods that have cleared customs but cannot enter commercial sale represent a regulatory and commercial deadlock that is expensive to resolve and cannot be corrected retroactively on the customs declaration.
Japan's cosmetics import pathway requires simultaneous attention to two independent regulatory layers. The customs structure, whether IOR or ACP, determines who is named on the import declaration, who bears customs and JCT liability, and what tax registration steps must be completed before the first shipment. The PAL Act layer determines who can lawfully market the product in Japan. Neither layer substitutes for the other, and each demands its own compliance preparation. For brands entering Japan without a resident entity, structuring the customs layer correctly at the outset eliminates the most common and most costly points of failure.
For a comparison of the two customs structures in full, see IOR vs ACP for Japan Imports. For the full ACP registration and setup sequence, see Japan ACP Registration and Setup Guide. For IOR mechanics for B2B manufacturers, see Japan IOR for B2B Manufacturers.
This article is informational only and does not constitute legal, tax, or regulatory advice. Japan's Pharmaceutical and Medical Device Act (薬機法) requirements for cosmetics and quasi-drugs are complex, subject to product-specific and claim-specific analysis, and may change. Before importing cosmetics for commercial sale in Japan, consult a qualified cosmetics regulatory specialist, a licensed customs specialist (通関士), and a tax accountant (税理士) with Japan experience. Aplash is a regulatory strategy and market entry firm. Last updated: July 2026.